Glucotrack GCTK
NASDAQ GCTK
$3.16 +0.02 (+0.64%)
As of: Sep 10, 2026 · 12:13 PM EDT

Glucotrack (GCTK) Total Debt Growth (1y) (2025 - 2026)

Analysis

Glucotrack (GCTK) Total Debt Growth (1y) (2025 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt Growth (1y) (Qtr)
1 Abbott Laboratories 181.19 Bn 175.58 Bn 7.27 Bn 142.67%
2 Intuitive Surgical 127.77 Bn 122.55 Bn 1.96 Bn -
3 Medtronic 117.13 Bn 108.31 Bn 6.34 Bn -1.59%
4 Stryker 104.67 Bn 101.20 Bn 4.50 Bn -9.88%
5 Boston Scientific 64.48 Bn 63.94 Bn 3.85 Bn 8.95%
6 Edwards Lifesciences 49.97 Bn 45.72 Bn 1.35 Bn 0.12%
7 Alcon 33.06 Bn 31.61 Bn 1.68 Bn -9.07%
8 Dexcom 32.37 Bn 30.43 Bn 830.00 Mn -
9 Steris 20.76 Bn 20.28 Bn 684.20 Mn 12.29%
10 Glucotrack 1.06 Mn -68,752.73 - 777.83%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 777.83%
Dec 31, 2025 1,540.87%
Sep 30, 2025 65,060.00%
Jun 30, 2025 1,741.67%